Lithium Controlled-Release and Extended-Release Tablets and Sodium Phenylbutyrate Powder
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Sodium Phenylbutyrate Powder and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium phenylbutyrate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Sodium Phenylbutyrate Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic
- Lithium Controlled-Release and Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Lithium Controlled-Release and Extended-Release Tablets-Sodium phosphate p 32 Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Sodium Phosphates
- Lithium Controlled-Release and Extended-Release Tablets-Sodium Phosphates Enema
- Sodium Phenylbutyrate Powder-Lithium ER
- Sodium Phenylbutyrate Powder-Lithium Oral Solution
- Sodium Phenylbutyrate Powder-Lithium Salts
- Sodium Phenylbutyrate Powder-Lithium Syrup and Oral Solution
- Sodium Phenylbutyrate Powder-Lithobid
- Sodium Phenylbutyrate Powder-Lithostat